NDC 42291-804

ALYQ

Tadalafil

ALYQ is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Avkare, Inc.. The primary component is Tadalafil.

• Product ID: 42291-804_826986ea-cbe2-f479-e053-2991aa0a1d64
• NDC: 42291-804
• Product Type: Human Prescription Drug
• Proprietary Name: ALYQ
• Generic Name: Tadalafil
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2019-02-18
• Marketing Category: ANDA / ANDA
• Application Number: ANDA209942
• Labeler Name: AvKARE, Inc.
• Substance Name: TADALAFIL
• Active Ingredient Strength: 20 mg/1
• Pharm Classes: Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2020-12-31

Packaging

NDC 42291-804-60

60 TABLET, FILM COATED in 1 BOTTLE (42291-804-60)

• Marketing Start Date: 2019-02-18
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 42291-804-60 [42291080460]

ALYQ TABLET, FILM COATED

• Marketing Category: ANDA
• Application Number: ANDA209942
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2019-02-18

Drug Details

Active Ingredients

Ingredient	Strength
TADALAFIL	20 mg/1

OpenFDA Data

• SPL SET ID: 81f4efca-0ce1-d975-e053-2a91aa0ae8b4
• Manufacturer:
  • AvKARE, Inc.
• UNII:
  • 742SXX0ICT
• UPC Code:
  • 0342291804609

Pharmacological Class

• Phosphodiesterase 5 Inhibitor [EPC]
• Phosphodiesterase 5 Inhibitors [MoA]
• Phosphodiesterase 5 Inhibitor [EPC]
• Phosphodiesterase 5 Inhibitors [MoA]

NDC Crossover Matching brand name "ALYQ" or generic name "Tadalafil"

NDC	Brand Name	Generic Name
0093-3334	ALYQ	Tadalafil
42291-804	ALYQ	ALYQ
0002-4462	Cialis	Tadalafil
0002-4463	Cialis	Tadalafil
0002-4464	Cialis	Tadalafil
0002-4465	Cialis	Tadalafil
0093-3016	Tadalafil	Tadalafil
0093-3017	Tadalafil	Tadalafil
0093-3018	Tadalafil	Tadalafil
0093-3019	Tadalafil	Tadalafil